Related Experiment Videos
[Blood coagulation factors in hepatic disorders]
1Japan Clinical Laboratories, Inc., Suita.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|December 1, 1992
Summary
The liver synthesizes key blood clotting and clot-dissolving factors. Measuring these hemostatic factors helps assess liver disease severity and treatment effectiveness.
Area of Science:
- Biochemistry
- Hematology
- Hepatology
Context:
- The liver plays a central role in synthesizing and clearing factors involved in the coagulo-fibrinolytic system.
- Hepatic cells are crucial for producing proteins essential for hemostasis and fibrinolysis.
- The liver's function as a reticuloendothelial organ aids in clearing activated clotting factors and byproducts.
Purpose:
- To present the recent understanding of the hemostatic mechanism.
- To explore the relationship between hemostatic factors and liver disorders.
- To highlight the diagnostic and prognostic potential of measuring these factors in hepatic diseases.
Summary:
- Coagulo-fibrinolytic reactions are primarily synthesized in hepatic cells, with the liver also clearing activated factors and metabolic products.
- Advances in blood coagulation reveal hemostasis as a critical mechanism for maintaining blood-flow homeostasis.
- The article discusses the roles of factors from platelets, vascular endothelial cells, and the liver, alongside measurable hemostatic molecular markers and activated factor-inhibitor complexes.
Impact:
- Provides insights into using hemostatic factor measurements for evaluating liver disease type and severity.
- Offers a basis for monitoring therapeutic effects and prognosis in patients with hepatic disorders.
- Integrates current concepts of hemostasis with the clinical implications for liver disease management.